HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zika virus has oncolytic activity against glioblastoma stem cells.

Abstract
Glioblastoma is a highly lethal brain cancer that frequently recurs in proximity to the original resection cavity. We explored the use of oncolytic virus therapy against glioblastoma with Zika virus (ZIKV), a flavivirus that induces cell death and differentiation of neural precursor cells in the developing fetus. ZIKV preferentially infected and killed glioblastoma stem cells (GSCs) relative to differentiated tumor progeny or normal neuronal cells. The effects against GSCs were not a general property of neurotropic flaviviruses, as West Nile virus indiscriminately killed both tumor and normal neural cells. ZIKV potently depleted patient-derived GSCs grown in culture and in organoids. Moreover, mice with glioblastoma survived substantially longer and at greater rates when the tumor was inoculated with a mouse-adapted strain of ZIKV. Our results suggest that ZIKV is an oncolytic virus that can preferentially target GSCs; thus, genetically modified strains that further optimize safety could have therapeutic efficacy for adult glioblastoma patients.
AuthorsZhe Zhu, Matthew J Gorman, Lisa D McKenzie, Jiani N Chai, Christopher G Hubert, Briana C Prager, Estefania Fernandez, Justin M Richner, Rong Zhang, Chao Shan, Eric Tycksen, Xiuxing Wang, Pei-Yong Shi, Michael S Diamond, Jeremy N Rich, Milan G Chheda
JournalThe Journal of experimental medicine (J Exp Med) Vol. 214 Issue 10 Pg. 2843-2857 (Oct 02 2017) ISSN: 1540-9538 [Electronic] United States
PMID28874392 (Publication Type: Journal Article)
Copyright© 2017 Zhu et al.
Chemical References
  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Temozolomide
Topics
  • Animals
  • Antineoplastic Agents, Alkylating (therapeutic use)
  • Brain Neoplasms (therapy, virology)
  • Cell Line, Tumor
  • Cell Proliferation
  • Chlorocebus aethiops
  • Combined Modality Therapy
  • Dacarbazine (analogs & derivatives, therapeutic use)
  • Female
  • Fluorescent Antibody Technique
  • Glioblastoma (therapy, virology)
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Neoplasms, Experimental (therapy, virology)
  • Neoplastic Stem Cells (virology)
  • Oncolytic Virotherapy (methods)
  • Temozolomide
  • Vero Cells
  • Zika Virus (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: